Atg16L1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about the subject and its role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
Protein Name: Autophagy-related protein 16-1
Gene: ATG16L1
UniProt ID: Q9Y5A7
PDB Structures: 4TQ8, 6AC0
Molecular Weight: ~66 kDa
Subcellular Localization: Cytoplasm, Autophagosome membrane
ATG16L1 forms an essential complex with ATG5 and ATG12:
- N-terminal Domain: Contains coiled-coil domain for ATG5 binding
- Linker Region: Flexible region connecting domains
- C-terminal WD40 Repeat Domain: Beta-propeller structure for protein interactions
- ATG5 Binding Region: Critical for complex formation
Key structural features:
- Homodimerizes through coiled-coil domain
- Forms 1:1 complex with ATG5
- WD40 domain mediates substrate specificity
ATG16L1 is the E3 ligase component of the LC3 lipidation system:
- ATG12-ATG5 complex: Acts as E1 and E2 enzyme
- ATG16L1: Provides E3 ligase activity for LC3/ATG8
- Membrane targeting: Recruits ATG3-LC3 to the autophagosome
- Selectivity: WD40 domain confers selectivity for different ATG8 family members
Functions in autophagy:
- LC3 conjugation: Facilitates LC3-I to LC3-II conversion
- Phagophore expansion: Supports membrane expansion
- Selective autophagy: Mediates receptor-mediated selective autophagy
- Closure: Helps in autophagosome closure
¶ Xenophagy and Anti-microbial Defense
In cellular immunity:
- Bacterial clearance: Recruits autophagy to intracellular bacteria
- Viral clearance: Targets viral components
- Antigen presentation: Links autophagy to MHC presentation
- Inflammasome regulation: Modulates inflammasome activity
In neurons specifically:
- Synaptic autophagy: Essential for synaptic protein turnover
- Axonal homeostasis: Maintains axonal protein quality
- Dendritic function: Supports dendritic spine dynamics
- Neuronal survival: Prevents accumulation of damaged components
ATG16L1 dysfunction in AD:
- Amyloid clearance: Impaired autophagic flux affects Aβ clearance
- Tau pathology: Altered LC3 lipidation impacts tau turnover
- Neuronal loss: Autophagy deficits contribute to neurodegeneration
- Synaptic dysfunction: Loss of synaptic autophagy
In PD pathogenesis:
- α-synuclein clearance: ATG16L1-mediated mitophagy clears α-synuclein
- PINK1/PARKIN pathway: Works with mitophagy receptors
- Dopaminergic neuron survival: Critical for mitochondrial quality control
- LRRK2 interaction: Mutant LRRK2 affects ATG16L1 function
ATG16L1 in ALS:
- TDP-43 clearance: Autophagy for aggregate removal
- Stress response: Modulates stress granule dynamics
- Motor neuron pathology: Dysfunction contributes to motor neuron disease
- Protein homeostasis: Maintains proteostasis
ATG16L1 is well-established in Crohn's:
- ATG16L1 T300A variant: Increased risk variant
- Paneth cell dysfunction: Affects secretory granules
- Autophagy impairment: Reduced antibacterial autophagy
- Inflammation: Dysregulated immune response
Targeting ATG16L1 pathway:
- Small molecule activators: Enhance ATG16L1 complex activity
- Phosphorylation modulators: Target upstream kinases
- Protein-protein interaction disruptors: For selective modulation
- ATG16L1 overexpression: Increase autophagic capacity
- Variant correction: Target specific disease variants
- Neuronal delivery: CNS-targeted gene therapy
- With mTOR inhibitors: Synergistic autophagy induction
- With抗氧化剂: Combined neuroprotection
- With mitophagy enhancers: Target mitochondrial dysfunction
ATG16L1 interacts with:
- ATG12-ATG5: Forms essential E3 ligase complex
- ATG5: Direct binding through coiled-coil domain
- ATG3: E2 enzyme for LC3 lipidation
- LC3/ATG8: Substrate for lipidation
- TBK1: Phosphorylates ATG16L1
- ULK1: Phosphorylates ATG16L1
- mTORC1: Inhibits ATG16L1 function
- AMPK: Activates under energy stress
- LRRK2: In Parkinson's disease
- TDP-43: In ALS
- APP: In Alzheimer's disease
ATG16L1 is a critical component of the autophagy machinery, forming the E3 ligase complex that catalyzes LC3 lipidation. This essential function makes it crucial for autophagosome formation and selective autophagy. In neurodegenerative diseases, ATG16L1 dysfunction contributes to impaired protein clearance, mitochondrial deficits, and neuronal death. The protein represents a promising therapeutic target for AD, PD, and ALS.
The study of Atg16L1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- ATG16L1 in autophagy and disease (Nature Reviews Molecular Cell Biology, 2023)
- ATG16L1 and neurodegeneration (Journal of Cell Biology, 2022)
- Autophagy in Parkinson's disease (Neuron, 2023)
- ATG16L1 variant and inflammatory disease (Nature Genetics, 2022)
- Targeting autophagy machinery for neuroprotection (Brain, 2023)